Ferinject (Ferric Carboxymaltose) SPC Overview
Quick summary: Ferinject is a prescription intravenous iron medicine containing ferric carboxymaltose. It is used to treat iron deficiency anaemia when oral iron is not suitable, not tolerated, or not effective. It is given...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary: Ferinject is a prescription intravenous iron medicine containing ferric carboxymaltose. It is used to treat iron deficiency anaemia when oral iron is not suitable, not tolerated, or not effective.
It is given in a clinical setting and monitored by healthcare professionals. The exact dose, infusion method, and follow-up depend on the patient’s iron needs and blood test results.
Medical disclaimer: This article is for general information only and does not replace the official product information, a pharmacist’s advice, or guidance from a qualified healthcare professional. Do not use it to self-diagnose or to change any treatment plan.
What is Ferinject?
Ferinject is a brand name for ferric carboxymaltose, an intravenous iron preparation. It is designed to help replenish iron stores in the body and support the treatment of iron deficiency anaemia (IDA).
According to the product description, each millilitre contains 50 mg of ferric carboxymaltose as a dark brown aqueous dispersion.
Because it is given directly into the bloodstream, Ferinject bypasses the digestive system. This can be useful when oral iron is ineffective, poorly tolerated, or unsuitable for a patient’s situation.
When might Ferinject be used?
Ferinject is typically considered when a healthcare professional decides that iron needs to be replaced intravenously rather than by mouth. The original content highlights use in people who cannot meet their iron needs with oral supplements.
Examples mentioned include:
- Chronic kidney disease
- Haemodialysis
- Heavy menstrual bleeding
- Inflammatory bowel disease
- Cancer treatment with chemotherapy
It may also be used when iron needs to be replenished more quickly, such as before surgery or after significant blood loss.
How is Ferinject given?
Ferinject is administered in a clinical setting such as a hospital or outpatient clinic. The original content states that it may be given as a slow intravenous injection or diluted in saline for infusion.
Administration is usually supervised by healthcare professionals who can monitor for any immediate reaction. The infusion time in the source content is described as typically 15 to 20 minutes.
After treatment, patients may be observed for a short period before leaving the clinic.
What dose is used?
The dose of Ferinject is individualised. The original content says it is based on factors such as body weight and haemoglobin levels.
Examples mentioned in the source include:
- An adult dose of 1,000 mg in a single infusion
- In some cases, an initial dose of 500 mg followed by further doses if needed
- Possible dose reduction in people with lower body weight
Blood tests are used to assess response and guide follow-up treatment.
What side effects are mentioned?
Like all medicines, Ferinject may cause side effects. The original content lists the following common effects:
- Headache
- Nausea
- Dizziness
- Flushing
More serious reactions can occur, including hypersensitivity reactions. The source content notes symptoms such as difficulty breathing, swelling of the face, lips, or throat, and a rapid heartbeat.
Anyone receiving an iron infusion should be monitored according to local clinical practice and should seek urgent medical help if severe symptoms develop.
What should patients do after the infusion?
After receiving Ferinject, the original content recommends simple follow-up steps:
- Rest and drink enough fluids
- Report persistent or concerning symptoms to a healthcare professional
- Attend any follow-up blood tests to check haemoglobin and iron status
Follow-up is important because the response to treatment is usually assessed with blood tests rather than symptoms alone.
Key points to verify with a doctor or pharmacist
If you are reading the official product information or discussing Ferinject with a clinician, it can help to confirm:
- Whether intravenous iron is appropriate in the first place
- The planned dose and infusion schedule
- How long observation should continue after administration
- Which blood tests will be used for monitoring
- What symptoms should prompt urgent medical review
This is especially important because dosing and monitoring are tailored to the individual patient.
Frequently asked questions
▸ Is ferric carboxymaltose the same as Ferinject?
Yes. Ferric carboxymaltose is the active ingredient, and Ferinject is the branded injectable product mentioned in this article.
▸ What is Ferinject used for?
It is used for iron deficiency anaemia when oral iron is ineffective, poorly tolerated, or not suitable, according to the source content.
▸ How is Ferinject administered?
It is given in a clinic or hospital setting as an intravenous injection or infusion, with monitoring during and after treatment.
▸ What side effects are mentioned in the article?
The source content lists headache, nausea, dizziness, and flushing, and also notes that hypersensitivity reactions can occur.
▸ Does the dose stay the same for everyone?
No. The article states that dosing is tailored to the patient’s weight, haemoglobin level, and treatment needs.
▸ What should happen after the infusion?
Patients are usually observed briefly, then advised to follow any monitoring plan and report concerning symptoms to a healthcare professional.
Safety reminder
Ferinject should only be given under appropriate clinical supervision. If you have symptoms such as breathing difficulty, facial swelling, or a rapid heartbeat after an infusion, seek urgent medical help. Always follow the official leaflet and the advice of the prescribing team.
Note: This overview is based on the supplied content and is not a substitute for the full SPC or patient information leaflet.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
- Ferinject Summary of Product Characteristics (SPC)
- Ferinject Patient Information Leaflet
- NHS: Iron deficiency anaemia
- British National Formulary (BNF)
To improve this article with specific references, add a custom field named _aio_sources in the post editor and write one source per line using: Source title|Source URL.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.